Company press releases
Tid | Selskap | Tittel | Sektor | Kategori |
---|---|---|---|---|
26 Sep 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 Sep 2024 12:15 CEST |
LIFECARE ASA | Lifecare ASA: Re-purchase of shares and warrants completed | 20103010 Biotechnology | Acquisition or disposal of the issuer’s own shares |
25 Sep 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Re-purchase of shares and warrants | 20103010 Biotechnology | Acquisition or disposal of the issuer’s own shares |
17 Sep 2024 11:00 CEST |
LIFECARE ASA | Minutes from Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
11 Sep 2024 07:00 CEST |
LIFECARE ASA | LIFE Successfully completes the first patient in the longevity trial after three months | 20103010 Biotechnology | Non-regulatory press releases |
03 Sep 2024 14:31 CEST |
LIFECARE ASA | LIFECARE ASA: Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
30 Aug 2024 16:18 CEST |
LIFECARE ASA | Euronext Oslo Børs - Mottatt søknad om opptak til handel – Lifecare ASA | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
30 Aug 2024 16:18 CEST |
LIFECARE ASA | Euronext Oslo Børs - Received application for admission to trading – Lifecare ASA | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
30 Aug 2024 15:50 CEST |
LIFECARE ASA | Correction: LIFE: Lifecare ASA Q2 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
27 Aug 2024 07:00 CEST |
LIFECARE ASA | LIFE: Lifecare ASA Q2 2024 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
22 Aug 2024 16:30 CEST |
LIFECARE ASA | Lifecare ASA Q2 2024 presentation | 20103010 Biotechnology | Non-regulatory press releases |
21 Aug 2024 07:00 CEST |
LIFECARE ASA | LIFE Successfully completed nine weeks of longevity trials | 20103010 Biotechnology | Non-regulatory press releases |
13 Aug 2024 07:00 CEST |
LIFECARE ASA | LIFE: Strategic cooperation to make glucose data more accessible | 20103010 Biotechnology | Inside information |
17 Jul 2024 08:00 CEST |
LIFECARE ASA | LIFE Successfully completed four weeks of longevity trials | 20103010 Biotechnology | Non-regulatory press releases |
05 Jul 2024 10:07 CEST |
LIFECARE ASA | Lifecare ASA: Share capital increase | 20103010 Biotechnology | Total number of voting rights and capital |
02 Jul 2024 17:25 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
02 Jul 2024 08:00 CEST |
LIFECARE ASA | LIFE: Cleanroom arrived in Hamburg | 20103010 Biotechnology | Non-regulatory press releases |
27 Jun 2024 08:00 CEST |
LIFECARE ASA | LIFE: Successfully completed first week of longevity trials | 20103010 Biotechnology | Non-regulatory press releases |
27 Jun 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Information about the warrants issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 Jun 2024 14:47 CEST |
LIFECARE ASA | Lifecare ASA: Share capital increase and warrants registered | 20103010 Biotechnology | Total number of voting rights and capital |
18 Jun 2024 08:00 CEST |
LIFECARE ASA | LIFE Longevity trials in dogs starts today | 20103010 Biotechnology | Non-regulatory press releases |
14 Jun 2024 16:31 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
14 Jun 2024 12:17 CEST |
LIFECARE ASA | LIFE: Satisfied with the final results of the Rights Issue | 20103010 Biotechnology | Non-regulatory press releases |
14 Jun 2024 12:11 CEST |
LIFECARE ASA | Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
13 Jun 2024 19:21 CEST |
LIFECARE ASA | Lifecare ASA: Preliminary results of the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
13 Jun 2024 14:33 CEST |
LIFECARE ASA | LIFE Successful in-vitro quality testing of sensor | 20103010 Biotechnology | Inside information |
13 Jun 2024 08:00 CEST |
LIFECARE ASA | Lifecare ASA: Last day of the Subscription Period in the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
12 Jun 2024 10:58 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
10 Jun 2024 10:45 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
10 Jun 2024 08:25 CEST |
LIFECARE ASA | LIFE Improved read out distance for sensor preparing for longevity trials in dogs | 20103010 Biotechnology | Inside information |
07 Jun 2024 13:21 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
07 Jun 2024 08:00 CEST |
LIFECARE ASA | Lifecare ASA: Last day of trading in Subscription Rights | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
06 Jun 2024 12:37 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
06 Jun 2024 08:00 CEST |
LIFECARE ASA | LIFE Sterilization protocol ready for the production line | 20103010 Biotechnology | Non-regulatory press releases |
04 Jun 2024 17:30 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
04 Jun 2024 08:00 CEST |
LIFECARE ASA | LIFE: Lifecare ASA has filed application for a new patent | 20103010 Biotechnology | Non-regulatory press releases |
30 May 2024 13:45 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade by primary insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
30 May 2024 08:30 CEST |
LIFECARE ASA | LIFE Lifecare CEO presents at Redeye Growth Day 2024 | 20103010 Biotechnology | Non-regulatory press releases |
30 May 2024 08:00 CEST |
LIFECARE ASA | Lifecare ASA: Commencement of the subscription period for the Rights Issue and start of trading in Subscription Rights | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
29 May 2024 13:45 CEST |
LIFECARE ASA | Lifecare ASA: FAQ regarding Rights Issue | 20103010 Biotechnology | Non-regulatory press releases |
29 May 2024 13:15 CEST |
LIFECARE ASA | Lifecare ASA: Registration of national prospectus for the preferential Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
21 May 2024 08:00 CEST |
LIFECARE ASA | LIFE Ex. Subscription Rights today | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
16 May 2024 13:25 CEST |
LIFECARE ASA | Minutes from Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
15 May 2024 20:18 CEST |
LIFECARE | Lifecare ASA: Updated key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
13 May 2024 08:00 CEST |
LIFECARE | LIFE Conversion to a public limited liability company registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
08 May 2024 08:00 CEST |
LIFECARE | Lifecare Q1 2024 Report From preparations phase to pilot production | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
07 May 2024 08:00 CEST |
LIFECARE | Lifecare Q1 2024 report and webcast | 20103010 Biotechnology | Non-regulatory press releases |
02 May 2024 20:41 CEST |
LIFECARE | Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
30 Apr 2024 15:40 CEST |
LIFECARE | Minutes from Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
29 Apr 2024 08:00 CEST |
LIFECARE | LIFE Lifecare becomes majority shareholder in RemovAid | 20103010 Biotechnology | Non-regulatory press releases |